Budczies, J, Kirchner, M, Kluck, K, Kazdal, D, Glade, J, Allgäuer, M, Kriegsmann, M, Heußel, C-P, Herth, FJ, Winter, H, Meister, M, Muley, T, Goldmann, T, Fröhling, S, Wermke, M, Waller, CF, Tufman, A, Reck, M, Peters, S, Schirmacher, P, Thomas, M, Christopoulos, P & Stenzinger, A 2022, 'Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinoma', CANCER IMMUNOLOGY IMMUNOTHERAPY, Jg. 71, Nr. 2, S. 251-265.

Dallenga, T, Linnemann, L & Schaible, UE 2022, 'Evaluation of Myeloperoxidase as Target for Host-Directed Therapy in Tuberculosis In Vivo', INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, Jg 23, Nr. 5, 2554.

Diricks, M, Kohl, TA, Käding, N, Leshchinskiy, V, Hauswaldt, S, Jiménez Vázquez, O, Utpatel, C, Niemann, S, Rupp, J & Merker, M 2022, 'Whole genome sequencing-based classification of human-related Haemophilus species and detection of antimicrobial resistance genes', Genome medicine, Jg. 14, Nr. 1, S. 13.

DZIF-TB cohort study group 2022, 'Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes', The European respiratory journal.

Elmas, H, Diel, R, Önal, B, Sauter, G, Stellmacher, F & Welker, L 2022, 'Recommendations for immunocytochemistry in lung cancer typing: An update on a resource-efficient approach with large-scale comparative Bayesian analysis', Cytopathology, Jg. 33, Nr. 1, S. 65-76.

Expert panel group for management recommendations in non-tuberculous mycobacterial pulmonary diseases 2022, 'Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases', Lancet Infectious Diseases.